NEW YORK, Jan. 29, 2016 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Identiv, Inc. securities (NASDAQ:INVE) from November 7, 2013 through November 23, 2015, all dates inclusive (the “Class Period”) of the important February 5, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Identiv investors under the federal securities laws.
To join the Identiv class action, go to the firm’s website at http://rosenlegal.com/cases-795.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email [email protected] or [email protected] for more information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE
According to the lawsuit, throughout the Class Period, defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Identiv had engaged in inappropriate revenue recognition practices; (2) Identiv’s senior management encouraged a closed and ineffective control environment; (3) Identiv’s key accounting metrics were misstated; (4) Identiv lacked adequate internal controls at all relevant times; and (5) as a result, defendants’ statements about Identiv’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 5, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-795.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 



